Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to evaluate the bioequivalence of a new formulation of
ibuprofen 400 mg/10 mL oral suspension vs. the marketed reference product MOMENTACT 400 mg
film-coated tablet, when administered under fasting conditions as single oral dose to healthy
male and female volunteers, in two consecutive study periods.